However, a recent study by the ONTARGET investigators26 showed that ramipril (ACE inhibitor) and telmisartan combination did not raise the rate of stroke, CVD or renal events in patients with DM compared with monotherapy groups. The gene discussed is ACE; the disease is stroke disorder.